PepGen Inc. Common Stock (PEPG)
Stock · NASDAQ · Health Care
$3.09as of 8/28/2026
Price chart
Open in TradingViewActive signals
High Beta43.4%
Support level
$1.63
Industry
Biotechnology: Pharmaceutical Preparations
About PEPG
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystr…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 59
- Website
- pepgen.com
Fundamentals
- 1-day range
- $2.44$2.88
- Market cap
- $166.70M
- P/E (trailing)
- —
- P/E (forward)
- -2.75
- EPS (trailing)
- $-1.30
- Dividend yield
- —
- Beta
- 1.99
- Avg. volume
- 919.1K
52-week range
$1.13$7.8
Next earnings: November 11, 2026 · EPS estimate $-0.28confirmed
Forecasts
7 analyst ratings
Buy 86%
Hold 7%
Sell 7%
1-year price forecast
High
$20
+548.3%
Median
$11
+256.6%
Low
$4
+29.7%
PepGen Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- PEPGPepGen Inc. Common Stock$3.09▲ 0.49%Market cap $166.70MP/E —$1.13$7.8
- INDPIndaptus Therapeutics Inc. Common Stock$1.15▼ 0.86%Market cap $166.55MP/E —$0.92$8.57
- OKUROnKure Therapeutics Inc. Class A Common Stock$3.78▼ 1.31%Market cap $168.06MP/E —$2.23$5.38
- ARCTArcturus Therapeutics Holdings Inc. Common Stock$15.19▼ 6.06%Market cap $172.81MP/E —$5.5$24.17
- AARDAardvark Therapeutics Inc. Common Stock$5.71▼ 13.75%Market cap $159.75MP/E —$3.35$17.94
- KRROKorro Bio Inc. Common Stock$12.94▼ 2.41%Market cap $174.80MP/E —$5.2$55.89
- MENSJyong Biotech Ltd. Ordinary Shares$2.37▲ 3.04%Market cap $153.58MP/E —$1.43$67
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| PEPG PepGen Inc. Common Stock | $166.70M | — | $3.09 | ▲ 0.49% | $1.13$7.8 |
| INDP Indaptus Therapeutics Inc. Common Stock | $166.55M | — | $1.15 | ▼ 0.86% | $0.92$8.57 |
| OKUR OnKure Therapeutics Inc. Class A Common Stock | $168.06M | — | $3.78 | ▼ 1.31% | $2.23$5.38 |
| ARCT Arcturus Therapeutics Holdings Inc. Common Stock | $172.81M | — | $15.19 | ▼ 6.06% | $5.5$24.17 |
| AARD Aardvark Therapeutics Inc. Common Stock | $159.75M | — | $5.71 | ▼ 13.75% | $3.35$17.94 |
| KRRO Korro Bio Inc. Common Stock | $174.80M | — | $12.94 | ▼ 2.41% | $5.2$55.89 |
| MENS Jyong Biotech Ltd. Ordinary Shares | $153.58M | — | $2.37 | ▲ 3.04% | $1.43$67 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Insider Activity
Insider Actions →Acquired
272.0K
Disposed
10.5K
- Wyman Lisa · June 18, 2026 · Grant34.0K
- Mayer Howard · June 18, 2026 · Grant34.0K
- Resnick Joshua · June 18, 2026 · Grant34.0K
- Dable Habib J · June 18, 2026 · Grant34.0K
- KEATING LAURIE · June 18, 2026 · Grant34.0K
- Finer Mitchell H. · June 18, 2026 · Grant34.0K
- RA Capital Healthcare Fund LP · June 18, 2026 · Grant34.0K
- Heidi Henson · June 18, 2026 · Grant34.0K
- Kasraian Kasra · May 21, 2026 · Sale1.2K @ $1.41
- Donnelly Noel · March 4, 2026 · Sale52 @ $6.33
- Donnelly Noel · March 4, 2026 · Sale2.0K @ $6.23
- McArthur James G · March 4, 2026 · Sale131 @ $6.33
- McArthur James G · March 4, 2026 · Sale5.1K @ $6.23
- STRECK PAUL · March 4, 2026 · Sale47 @ $6.29
- STRECK PAUL · March 4, 2026 · Sale1.8K @ $6.23
Institutional Ownership
March 31, 2026
- Total shares held
- 56.36M
- Total value held
- $99.54M
- Institutional holders
- 91
Top holders this quarter
- Unknown20.06M
- Unknown4.47M
- Unknown3.48M
- Unknown2.75M
- Unknown2.33M
- Unknown2.08M
- Unknown1.94M
- Unknown1.83M
- Unknown1.61M
- Unknown1.31M
See the full, filterable feed with live charts on the MarketWall dashboard.